BridgeBio Revenue and Competitors
Estimated Revenue & Valuation
- BridgeBio's estimated annual revenue is currently $57M per year.
- BridgeBio's estimated revenue per employee is $91,120
- BridgeBio's total funding is $434M.
- BridgeBio's current valuation is $1.9B. (January 2022)
Employee Data
- BridgeBio has 625 Employees.
- BridgeBio grew their employee count by 44% last year.
BridgeBio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Regulatory Affairs Officer | Reveal Email/Phone |
2 | Chief Legal Officer | Reveal Email/Phone |
3 | CSO, BridgeBio Oncology Therapeutics | Reveal Email/Phone |
4 | CEO Oncology R&D at BridgeBio | Reveal Email/Phone |
5 | CEO and Founder | Reveal Email/Phone |
6 | CFO | Reveal Email/Phone |
7 | VP, Global Product Strategy - Lifecycle Leader Acoramidis | Reveal Email/Phone |
8 | SVP Patient Safety and Pharmacovigilance | Reveal Email/Phone |
9 | EVP, Corporate Development | Reveal Email/Phone |
10 | VP, Regulatory Affairs | Reveal Email/Phone |
BridgeBio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is BridgeBio?
We focus on accelerating and maximizing value in early-stage, genetic disease assets by applying our management expertise and proprietary platform. Our team picks the right assets based on our systematic mapping of the genetic disease landscape, and develops those assets with the right approach, supporting R&D with expert capabilities and placing them in a value maximizing corporate structure.
keywords:Biotechnology
$434M
Total Funding
625
Number of Employees
$57M
Revenue (est)
44%
Employee Growth %
$1.9B
Valuation
N/A
Accelerator
BridgeBio News
BridgeBio Pharma, a young biotech trying to bring its first drug to market, followed the blueprint of one of the world's largest...
Over the past month, the Zacks Consensus EPS estimate remained stagnant. BridgeBio Pharma is holding a Zacks Rank of #3 (Hold) right now. The...
About BridgeBio Pharma, Inc. BridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create,...
Other Companies in Palo Alto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $136.3M | 671 | 21% | $191.6M |
#2 | $122.9M | 678 | -2% | N/A |
#3 | $121.4M | 683 | -6% | N/A |
#4 | $100.8M | 706 | 7% | N/A |
#5 | $134.4M | 723 | 4% | $881M |